The signaling effects of incremental information: Evidence from stacked US Food and Drug Administration designations

Kathleen L. Miller, Clark Nardinelli, George Pink and Kristin Reiter

The Quarterly Review of Economics and Finance, 2018, vol. 67, issue C, 219-226

Abstract: The US Food and Drug Administration offers multiple designations for drugs under development, such as the fast-track designation (for drugs that treat serious conditions with unmet medical need) and the orphan drug designation (for drugs that treat rare diseases). In this study, we look at whether a stacked designation (a fast-track designation with a prior orphan designation) provides stronger positive signaling effects to investors than an unstacked designation (a fast-track alone). We examine differences in average cumulative abnormal returns (CARs) following “stacked” and “unstacked” announcements using daily stock data for individual firms and the S&P 500 Composite Index for the period of 1998–2015. Results show a substantial decline in average CARs over the study period for both stacked and unstacked designations. We hypothesize that this decline could be caused by the increased availability of information caused by the growth of the internet over the study period: as more information is more readily available, the value of each piece of incremental information may decrease. We also find evidence of substantially larger average CARs for small firms than large firms for both stacked and unstacked designations. We believe that this evidence supports the conclusion that there is a strong “dilution effect” for incremental information, as large pharmaceutical firms make more frequent announcements than smaller firms.

Keywords: Signaling; Event study; Market model; Pharmaceuticals; FDA; Incremental information (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S1062976917302120
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:quaeco:v:67:y:2018:i:c:p:219-226

DOI: 10.1016/j.qref.2017.07.005

Access Statistics for this article

The Quarterly Review of Economics and Finance is currently edited by R. J. Arnould and J. E. Finnerty

More articles in The Quarterly Review of Economics and Finance from Elsevier
Bibliographic data for series maintained by Catherine Liu ().